Partners Group, a global private markets firm, has acquired restor3d, a leader in patient-specific, 3D printed musculoskeletal implants, for an undisclosed amount. This transaction marks a significant corporate acquisition in the medical technology sector, with Partners Group taking ownership of restor3d to support its continued growth and innovation.
restor3d specializes in advanced 3D printing of osseointegrative materials, utilizing AI-based planning and design automation tools, alongside digital health solutions. The company's focus is on providing seamless, data-backed care to optimize individual patient outcomes and reimagine the musculoskeletal reconstruction landscape with personalized implants. Its solutions are designed to match unique patient anatomies, enhancing fit, function, and surgical outcomes across areas like foot and ankle, knee, and hip.
The acquisition is strategically driven by Partners Group's intent to invest in and scale companies with innovative technologies and strong market potential. Through this purchase, Partners Group aims to leverage its operational expertise and global network to accelerate restor3d's market penetration and expand its range of personalized orthopedic solutions. This synergy is expected to enhance restor3d's ability to deliver its advanced patient-specific products to a wider audience of healthcare professionals and patients.
The combined entity is positioned to further advance personalized orthopedic care, driven by restor3d’s technological leadership and Partners Group’s strategic backing. This collaboration is set to deepen the impact of 3D printing and AI in musculoskeletal surgery, promoting better patient outcomes and transforming the approach to reconstructive procedures globally.